Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$20.69 - $20.91 $29,441 - $29,754
-1,423 Reduced 57.26%
1,062 $52,000
Q1 2022

May 16, 2022

SELL
$15.96 - $18.87 $7,660 - $9,057
-480 Reduced 16.19%
2,485 $42,000
Q2 2021

Aug 13, 2021

SELL
$25.24 - $30.86 $28,697 - $35,087
-1,137 Reduced 27.72%
2,965 $80,000
Q1 2021

May 14, 2021

SELL
$28.29 - $39.89 $34,344 - $48,426
-1,214 Reduced 22.84%
4,102 $123,000
Q2 2020

Aug 11, 2020

BUY
$6.46 - $19.27 $31,240 - $93,189
4,836 Added 1007.5%
5,316 $96,000
Q4 2019

Feb 14, 2020

SELL
$8.8 - $14.93 $6,336 - $10,749
-720 Reduced 60.0%
480 $6,000
Q1 2019

May 15, 2019

BUY
$31.52 - $46.19 $37,824 - $55,428
1,200 New
1,200 $38,000

Others Institutions Holding CVET

About COVETRUS, INC.


  • Ticker CVET
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Distribution
  • Shares Outstandng 140,123,008
  • Description
  • Covetrus, Inc., together with its subsidiaries, operates as an animal-health technology and services company. It engages in the sale of animal-health consumable products, including proprietary and Covetrus branded products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vacc...
More about CVET
Track This Portfolio

Track Macquarie Group LTD Portfolio

Follow Macquarie Group LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Macquarie Group LTD, based on Form 13F filings with the SEC.

News

Stay updated on Macquarie Group LTD with notifications on news.